Catégories
-
Adhesives
6
Amines
115
Amino Acids
207
Analytical Reagents
750
Antibiotics
270
Bioactive Small Molecules
798
Aroma Chemicals
242
Biochemicals
1142
Boronic Acids
4
Buffers
104
Building Blocks
2162
Carbohydrates
191
Catalysts
117
Chiral Compounds
78
Coccus nucifera oil
0
Detergents
62
Diagnostic Raw Materials
271
Flavours and Fragrance Materials
234
Fluorinated Products
67
Furans
7
Gases in Solution
51
Grignard Reagents
31
HPLC Reagents
8
Imidazoles
18
Indoles
48
Inorganic Chemicals
357
Ion-Pair Reagents
23
Ligands
81
Organics
1628
Oxazoles
3
Peptide Reagents
99
Phenols
55
Picolines
0
Piperazines
13
Pyrazines
3
Pyridines
65
Pyrimidines
36
Quaternary Ammonium salts
45
Reagents
114
Research Organics & Inorganics
885
Salts
308
Sealing Compounds
1
Sherclin
1
Solvents
132
Stains & Indicators
322
Sugars
66
Tailor-made solutions
1
Testing Standards
4
Uncategorised
22
Water Analysis
13
Danofloxacin mesylate
(89967722 | 119478-55-6)
CAS: | 119478-55-6 |
---|---|
Formule moléculaire: | C20H24FN3O6S |
Masse moléculaire: | 453.49 |
Disponibilité: | En stock |
---|---|
Téléchargements: | | |
89967722-1g | 1g | £151.10 | |
Commande en vrac |
89967722-1g | 1g | €211.60 | |
Commande en vrac |
89967722-1g | 1g | $226.70 | |
Commande en vrac |
Fiche de données de sécurité
Certificat d'analyse
Détails du produit
Product Code | 89967722 | ||||
Product Name | Danofloxacin mesylate | ||||
Categories | Antibiotics Bioactive Small Molecules Research Organics & Inorganics | ||||
CAS | 119478-55-6 | ||||
Molecular Formula | C20H24FN3O6S | ||||
Molecular Weight | 453.49 | ||||
Storage Details | 2 to 8 °C | ||||
Harmonised Tariff Code | 2933599590 |
Spécifications du produit
Heavy metals | ≤ 20ppm | ||||
pH | 3.5 - 4.5 | ||||
Loss on Drying | ≤ 5.0% (120°C) | ||||
Assay | ≥ 98.5% | ||||
Related Substances | ≤ 1.5% | ||||
Residue on Ignition | ≤ 0.2% | ||||
Appearance | White to light yellow crystalline powder | ||||
Fluoride | ≥ 3.8% |
Informations sur la sécurité
Pictograms |
|
||||
Signal word | warning | ||||
Hazard statements |
|
||||
Precautionary statements |
|